search
Back to results

Investigating the Effectiveness of PelvicSense(R) on Pain and Sexual Outcomes in Provoked Vestibulodynia

Primary Purpose

Provoked Vestibulodynia

Status
Recruiting
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
PelvicSense(R)
Sponsored by
Queen's University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Provoked Vestibulodynia

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria: 18 years or older fluent in English have a formal diagnosis of PVD for at least 3 months Exclusion Criteria: younger than 18 years of age nonfluent in English self-identified diagnosis PVD duration of less than 3 months

Sites / Locations

  • Sexual Health Research Laboratory, Department of Psychology, Queen's UniversityRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

3 month PelvicSense(R) program

Arm Description

PelvicSense® is a home-based physiotherapy program integrating multiple techniques, including relaxation, breathing, stretching, strengthening and at-home manual therapy. This program also educates participants about the anatomy and physiology of the pelvis and teaches strategies to strengthen the mind-muscle connection to the pelvis.

Outcomes

Primary Outcome Measures

Pain intensity
Pain Intensity Numerical Rating Scale (NRS). Participants will be asked to report their pain intensity on an 11-point numerical scale of 0 (no pain) to 10 (worst pain ever felt).
Pain intensity
Pain Intensity Numerical Rating Scale (NRS). Participants will be asked to report their pain intensity on an 11-point numerical scale of 0 (no pain) to 10 (worst pain ever felt).
Pain intensity
Pain Intensity Numerical Rating Scale (NRS). Participants will be asked to report their pain intensity on an 11-point numerical scale of 0 (no pain) to 10 (worst pain ever felt).

Secondary Outcome Measures

Pain catastrophizing
Pain Catastrophizing Scale (PCS). 13 items rated on 5 point scales from 0 (not at all) to 4 (all the time). Total scores range from 0-52. Higher scores are worse.
Pain catastrophizing
Pain Catastrophizing Scale (PCS). 13 items rated on 5 point scales from 0 (not at all) to 4 (all the time). Total scores range from 0-52. Higher scores are worse.
Pain catastrophizing
Pain Catastrophizing Scale (PCS). 13 items rated on 5 point scales from 0 (not at all) to 4 (all the time). Total scores range from 0-52. Higher scores are worse.

Full Information

First Posted
May 5, 2023
Last Updated
June 23, 2023
Sponsor
Queen's University
search

1. Study Identification

Unique Protocol Identification Number
NCT05909514
Brief Title
Investigating the Effectiveness of PelvicSense(R) on Pain and Sexual Outcomes in Provoked Vestibulodynia
Official Title
Investigating the Effectiveness of PelvicSense(R) on Pain and Sexual Outcomes in Provoked Vestibulodynia
Study Type
Interventional

2. Study Status

Record Verification Date
June 2023
Overall Recruitment Status
Recruiting
Study Start Date
February 25, 2023 (Actual)
Primary Completion Date
June 30, 2024 (Anticipated)
Study Completion Date
March 31, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Queen's University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study will examine the effectiveness of the PelvicSense 3-month online program on pain and other outcomes in those with provoked vestibulodynia. This study is prospective in nature and will involve several assessment points: baseline, immediately post-treatment (at the end of the 3 month program), and 3-month follow up. All aspects of the study will be conducted remotely (e.g., online, email, video calls), and participants will be at least 18 years of age, fluent in English, and experience pain due to provoked vestibulodynia for at least 3 months with a physician diagnosis. Participants are expected to continue their treatment as usual and this information will be documented throughout the study.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Provoked Vestibulodynia

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
50 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
3 month PelvicSense(R) program
Arm Type
Experimental
Arm Description
PelvicSense® is a home-based physiotherapy program integrating multiple techniques, including relaxation, breathing, stretching, strengthening and at-home manual therapy. This program also educates participants about the anatomy and physiology of the pelvis and teaches strategies to strengthen the mind-muscle connection to the pelvis.
Intervention Type
Behavioral
Intervention Name(s)
PelvicSense(R)
Intervention Description
PelvicSense® is a home-based physiotherapy program integrating multiple techniques, including relaxation, breathing, stretching, strengthening and at-home manual therapy. This program also educates participants about the anatomy and physiology of the pelvis and teaches strategies to strengthen the mind-muscle connection to the pelvis.
Primary Outcome Measure Information:
Title
Pain intensity
Description
Pain Intensity Numerical Rating Scale (NRS). Participants will be asked to report their pain intensity on an 11-point numerical scale of 0 (no pain) to 10 (worst pain ever felt).
Time Frame
Baseline
Title
Pain intensity
Description
Pain Intensity Numerical Rating Scale (NRS). Participants will be asked to report their pain intensity on an 11-point numerical scale of 0 (no pain) to 10 (worst pain ever felt).
Time Frame
At the end of the 3 month program
Title
Pain intensity
Description
Pain Intensity Numerical Rating Scale (NRS). Participants will be asked to report their pain intensity on an 11-point numerical scale of 0 (no pain) to 10 (worst pain ever felt).
Time Frame
3 months after the end of the program
Secondary Outcome Measure Information:
Title
Pain catastrophizing
Description
Pain Catastrophizing Scale (PCS). 13 items rated on 5 point scales from 0 (not at all) to 4 (all the time). Total scores range from 0-52. Higher scores are worse.
Time Frame
Baseline
Title
Pain catastrophizing
Description
Pain Catastrophizing Scale (PCS). 13 items rated on 5 point scales from 0 (not at all) to 4 (all the time). Total scores range from 0-52. Higher scores are worse.
Time Frame
At the end of the 3 month program
Title
Pain catastrophizing
Description
Pain Catastrophizing Scale (PCS). 13 items rated on 5 point scales from 0 (not at all) to 4 (all the time). Total scores range from 0-52. Higher scores are worse.
Time Frame
3 months after the end of the program
Other Pre-specified Outcome Measures:
Title
Sexual distress
Description
Sexual Distress Scale, Short Form (SDS-SF). 5 items rated on 5 point scales from 0 (never) to 4 (always). Total scores range from 0-20. Higher scores are worse.
Time Frame
Baseline
Title
Sexual distress
Description
Sexual Distress Scale, Short Form (SDS-SF). 5 items rated on 5 point scales from 0 (never) to 4 (always). Total scores range from 0-20. Higher scores are worse.
Time Frame
At the end of the 3 month program
Title
Sexual distress
Description
Sexual Distress Scale, Short Form (SDS-SF). 5 items rated on 5 point scales from 0 (never) to 4 (always). Total scores range from 0-20. Higher scores are worse.
Time Frame
3 months after the end of the program
Title
Pain self-efficacy
Description
Pain Self-Efficacy Questionnaire (PSEQ). 10 items rated on 7 point scales from 0 (not at all confident) to 6 (completely confident). Total scores range from 0-60. Higher scores are better.
Time Frame
Baseline
Title
Pain self-efficacy
Description
Pain Self-Efficacy Questionnaire (PSEQ). 10 items rated on 7 point scales from 0 (not at all confident) to 6 (completely confident). Total scores range from 0-60.
Time Frame
At the end of the 3 month program
Title
Pain self-efficacy
Description
Pain Self-Efficacy Questionnaire (PSEQ). 10 items rated on 7 point scales from 0 (not at all confident) to 6 (completely confident). Total scores range from 0-60.
Time Frame
3 months after the end of the program

10. Eligibility

Sex
Female
Gender Based
Yes
Gender Eligibility Description
All identities accepted with female pelvic anatomy.
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: 18 years or older fluent in English have a formal diagnosis of PVD for at least 3 months Exclusion Criteria: younger than 18 years of age nonfluent in English self-identified diagnosis PVD duration of less than 3 months
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Caroline Pukall, PhD
Phone
613 533 3200
Email
caroline.pukall@queensu.ca
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Caroline Pukall, PhD
Organizational Affiliation
Queen's University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Sexual Health Research Laboratory, Department of Psychology, Queen's University
City
Kingston
State/Province
Ontario
ZIP/Postal Code
K7L 3N6
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Caroline Pukall, PhD
Phone
613 533 3200
Email
caroline.pukall@queensu.ca
First Name & Middle Initial & Last Name & Degree
Shannon Coyle, MA
Phone
613 533 3276
Email
shannon.coyle13@gmail.com

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
De-identified data will be available to other researchers after publication of the results.
IPD Sharing Time Frame
De-identified data will be available to other researchers for 2 years after publication of the results.
IPD Sharing Access Criteria
Please email the PI at caroline.pukall@queensu.ca

Learn more about this trial

Investigating the Effectiveness of PelvicSense(R) on Pain and Sexual Outcomes in Provoked Vestibulodynia

We'll reach out to this number within 24 hrs